ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gadoterate Meglumine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-35Z9996
Home | Market Reports | Health| Pharmacy
Global Gadoterate Meglumine Market Insights Forecast to 2028
BUY CHAPTERS

Global Gadoterate Meglumine Market Research Report 2025

Code: QYRE-Auto-35Z9996
Report
July 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Guerbet Group
Hengrui Medicine
GE Healthcare

Gadoterate Meglumine Market Size

The global market for Gadoterate Meglumine was valued at US$ 459 million in the year 2024 and is projected to reach a revised size of US$ 664 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Gadoterate Meglumine Market

Gadoterate Meglumine Market

Gadoterate meglumine, also known as gadoterate dimeglumine, is a gadolinium-based contrast agent commonly used in magnetic resonance imaging (MRI) to enhance the visibility of specific tissues, blood vessels, and abnormalities during imaging procedures. It is administered intravenously to improve the diagnostic quality and accuracy of MRI scans by providing contrast enhancement.
Market Drivers:
Improved Imaging Quality: Gadoterate meglumine enhances the quality and detail of MRI images, allowing healthcare professionals to visualize and evaluate internal structures, organs, and abnormalities with greater clarity and precision for accurate diagnosis and treatment planning.
Safety Profile: Compared to some other gadolinium-based contrast agents, gadoterate meglumine has a favorable safety profile with a lower risk of adverse reactions, making it a preferred choice for patients with a history of contrast allergies or renal impairment who require contrast-enhanced MRI studies.
Renal Safety: Gadoterate meglumine is considered safer for patients with renal insufficiency or at risk of contrast-induced nephropathy (CIN) due to its lower nephrotoxicity and reduced potential for causing renal complications following contrast administration.
Versatile Applications: Gadoterate meglumine is used in a wide range of clinical applications, including neuroimaging, musculoskeletal imaging, vascular imaging, and oncologic imaging, expanding its market demand and adoption across various medical specialties and diagnostic scenarios.
Technological Advancements: Ongoing advancements in MRI technology, imaging protocols, and software applications complement the use of gadoterate meglumine, enabling healthcare providers to optimize imaging parameters, acquire high-quality diagnostic images, and enhance the diagnostic capabilities of MRI studies.
Market Challenges:
Regulatory Compliance: Compliance with stringent regulatory requirements, safety standards, and labeling guidelines for gadoterate meglumine production, distribution, and administration is essential to ensure product quality, consistency, and adherence to regulatory approvals for market entry and use.
Competitive Landscape: The market for gadolinium-based contrast agents, including gadoterate meglumine, is competitive and subject to pricing pressures, market saturation, and challenges in differentiating products based on efficacy, safety, cost-effectiveness, and market share.
Cost Considerations: The cost of gadoterate meglumine and associated MRI procedures can influence its adoption, accessibility, and affordability for healthcare facilities, patients, and healthcare systems, particularly in the context of budget constraints, reimbursement limitations, and cost-effectiveness considerations.
Gadolinium Retention Concerns: Like other gadolinium-based contrast agents, gadoterate meglumine is associated with the risk of gadolinium retention in tissues, particularly in patients with impaired renal function, leading to ongoing concerns, research, and regulatory actions related to gadolinium deposition and long-term safety implications.
Patient Factors: Variability in patient factors such as allergies, renal function, comorbidities, medication history, and risk profiles can influence the choice of gadoterate meglumine, dosing considerations, and risk assessment for contrast-enhanced MRI studies, necessitating personalized approaches to patient care and contrast administration.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gadoterate Meglumine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gadoterate Meglumine.
The Gadoterate Meglumine market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gadoterate Meglumine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gadoterate Meglumine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gadoterate Meglumine Market Report

Report Metric Details
Report Name Gadoterate Meglumine Market
Accounted market size in year US$ 459 million
Forecasted market size in 2031 US$ 664 million
CAGR 5.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 1.8845Gm/5Ml
  • 3.769Gm/10Ml
  • 5.6535Gm/15Ml
  • Others
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Guerbet Group, Hengrui Medicine, GE Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gadoterate Meglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gadoterate Meglumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Gadoterate Meglumine Market growing?

Ans: The Gadoterate Meglumine Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Gadoterate Meglumine Market size in 2031?

Ans: The Gadoterate Meglumine Market size in 2031 will be US$ 664 million.

Who are the main players in the Gadoterate Meglumine Market report?

Ans: The main players in the Gadoterate Meglumine Market are Guerbet Group, Hengrui Medicine, GE Healthcare

What are the Application segmentation covered in the Gadoterate Meglumine Market report?

Ans: The Applications covered in the Gadoterate Meglumine Market report are Hospitals, Clinics

What are the Type segmentation covered in the Gadoterate Meglumine Market report?

Ans: The Types covered in the Gadoterate Meglumine Market report are 1.8845Gm/5Ml, 3.769Gm/10Ml, 5.6535Gm/15Ml, Others

Recommended Reports

MRI Contrast Agents

Magnetic Resonance Imaging

Imaging Therapeutics

1 Gadoterate Meglumine Market Overview
1.1 Product Definition
1.2 Gadoterate Meglumine by Type
1.2.1 Global Gadoterate Meglumine Market Value Comparison by Type (2024 VS 2031)
1.2.2 1.8845Gm/5Ml
1.2.3 3.769Gm/10Ml
1.2.4 5.6535Gm/15Ml
1.2.5 Others
1.3 Gadoterate Meglumine by Application
1.3.1 Global Gadoterate Meglumine Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Gadoterate Meglumine Market Size Estimates and Forecasts
1.4.1 Global Gadoterate Meglumine Revenue 2020-2031
1.4.2 Global Gadoterate Meglumine Sales 2020-2031
1.4.3 Global Gadoterate Meglumine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gadoterate Meglumine Market Competition by Manufacturers
2.1 Global Gadoterate Meglumine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gadoterate Meglumine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gadoterate Meglumine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gadoterate Meglumine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gadoterate Meglumine, Product Type & Application
2.7 Global Key Manufacturers of Gadoterate Meglumine, Date of Enter into This Industry
2.8 Global Gadoterate Meglumine Market Competitive Situation and Trends
2.8.1 Global Gadoterate Meglumine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gadoterate Meglumine Players Market Share by Revenue
2.8.3 Global Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gadoterate Meglumine Market Scenario by Region
3.1 Global Gadoterate Meglumine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gadoterate Meglumine Sales by Region: 2020-2031
3.2.1 Global Gadoterate Meglumine Sales by Region: 2020-2025
3.2.2 Global Gadoterate Meglumine Sales by Region: 2026-2031
3.3 Global Gadoterate Meglumine Revenue by Region: 2020-2031
3.3.1 Global Gadoterate Meglumine Revenue by Region: 2020-2025
3.3.2 Global Gadoterate Meglumine Revenue by Region: 2026-2031
3.4 North America Gadoterate Meglumine Market Facts & Figures by Country
3.4.1 North America Gadoterate Meglumine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gadoterate Meglumine Sales by Country (2020-2031)
3.4.3 North America Gadoterate Meglumine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gadoterate Meglumine Market Facts & Figures by Country
3.5.1 Europe Gadoterate Meglumine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gadoterate Meglumine Sales by Country (2020-2031)
3.5.3 Europe Gadoterate Meglumine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gadoterate Meglumine Market Facts & Figures by Region
3.6.1 Asia Pacific Gadoterate Meglumine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gadoterate Meglumine Sales by Region (2020-2031)
3.6.3 Asia Pacific Gadoterate Meglumine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gadoterate Meglumine Market Facts & Figures by Country
3.7.1 Latin America Gadoterate Meglumine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gadoterate Meglumine Sales by Country (2020-2031)
3.7.3 Latin America Gadoterate Meglumine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gadoterate Meglumine Market Facts & Figures by Country
3.8.1 Middle East and Africa Gadoterate Meglumine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gadoterate Meglumine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gadoterate Meglumine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gadoterate Meglumine Sales by Type (2020-2031)
4.1.1 Global Gadoterate Meglumine Sales by Type (2020-2025)
4.1.2 Global Gadoterate Meglumine Sales by Type (2026-2031)
4.1.3 Global Gadoterate Meglumine Sales Market Share by Type (2020-2031)
4.2 Global Gadoterate Meglumine Revenue by Type (2020-2031)
4.2.1 Global Gadoterate Meglumine Revenue by Type (2020-2025)
4.2.2 Global Gadoterate Meglumine Revenue by Type (2026-2031)
4.2.3 Global Gadoterate Meglumine Revenue Market Share by Type (2020-2031)
4.3 Global Gadoterate Meglumine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gadoterate Meglumine Sales by Application (2020-2031)
5.1.1 Global Gadoterate Meglumine Sales by Application (2020-2025)
5.1.2 Global Gadoterate Meglumine Sales by Application (2026-2031)
5.1.3 Global Gadoterate Meglumine Sales Market Share by Application (2020-2031)
5.2 Global Gadoterate Meglumine Revenue by Application (2020-2031)
5.2.1 Global Gadoterate Meglumine Revenue by Application (2020-2025)
5.2.2 Global Gadoterate Meglumine Revenue by Application (2026-2031)
5.2.3 Global Gadoterate Meglumine Revenue Market Share by Application (2020-2031)
5.3 Global Gadoterate Meglumine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Guerbet Group
6.1.1 Guerbet Group Company Information
6.1.2 Guerbet Group Description and Business Overview
6.1.3 Guerbet Group Gadoterate Meglumine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Guerbet Group Gadoterate Meglumine Product Portfolio
6.1.5 Guerbet Group Recent Developments/Updates
6.2 Hengrui Medicine
6.2.1 Hengrui Medicine Company Information
6.2.2 Hengrui Medicine Description and Business Overview
6.2.3 Hengrui Medicine Gadoterate Meglumine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hengrui Medicine Gadoterate Meglumine Product Portfolio
6.2.5 Hengrui Medicine Recent Developments/Updates
6.3 GE Healthcare
6.3.1 GE Healthcare Company Information
6.3.2 GE Healthcare Description and Business Overview
6.3.3 GE Healthcare Gadoterate Meglumine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GE Healthcare Gadoterate Meglumine Product Portfolio
6.3.5 GE Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gadoterate Meglumine Industry Chain Analysis
7.2 Gadoterate Meglumine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gadoterate Meglumine Production Mode & Process Analysis
7.4 Gadoterate Meglumine Sales and Marketing
7.4.1 Gadoterate Meglumine Sales Channels
7.4.2 Gadoterate Meglumine Distributors
7.5 Gadoterate Meglumine Customer Analysis
8 Gadoterate Meglumine Market Dynamics
8.1 Gadoterate Meglumine Industry Trends
8.2 Gadoterate Meglumine Market Drivers
8.3 Gadoterate Meglumine Market Challenges
8.4 Gadoterate Meglumine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Guerbet Group
Hengrui Medicine
GE Healthcare
List of Tables
 Table 1. Global Gadoterate Meglumine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gadoterate Meglumine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gadoterate Meglumine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gadoterate Meglumine Sales (K L) of Key Manufacturers (2020-2025)
 Table 5. Global Gadoterate Meglumine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gadoterate Meglumine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gadoterate Meglumine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gadoterate Meglumine Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gadoterate Meglumine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gadoterate Meglumine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gadoterate Meglumine, Product Type & Application
 Table 12. Global Key Manufacturers of Gadoterate Meglumine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gadoterate Meglumine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gadoterate Meglumine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gadoterate Meglumine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gadoterate Meglumine Sales by Region (2020-2025) & (K L)
 Table 18. Global Gadoterate Meglumine Sales Market Share by Region (2020-2025)
 Table 19. Global Gadoterate Meglumine Sales by Region (2026-2031) & (K L)
 Table 20. Global Gadoterate Meglumine Sales Market Share by Region (2026-2031)
 Table 21. Global Gadoterate Meglumine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gadoterate Meglumine Revenue Market Share by Region (2020-2025)
 Table 23. Global Gadoterate Meglumine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gadoterate Meglumine Revenue Market Share by Region (2026-2031)
 Table 25. North America Gadoterate Meglumine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gadoterate Meglumine Sales by Country (2020-2025) & (K L)
 Table 27. North America Gadoterate Meglumine Sales by Country (2026-2031) & (K L)
 Table 28. North America Gadoterate Meglumine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gadoterate Meglumine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gadoterate Meglumine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gadoterate Meglumine Sales by Country (2020-2025) & (K L)
 Table 32. Europe Gadoterate Meglumine Sales by Country (2026-2031) & (K L)
 Table 33. Europe Gadoterate Meglumine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gadoterate Meglumine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gadoterate Meglumine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gadoterate Meglumine Sales by Region (2020-2025) & (K L)
 Table 37. Asia Pacific Gadoterate Meglumine Sales by Region (2026-2031) & (K L)
 Table 38. Asia Pacific Gadoterate Meglumine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gadoterate Meglumine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gadoterate Meglumine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gadoterate Meglumine Sales by Country (2020-2025) & (K L)
 Table 42. Latin America Gadoterate Meglumine Sales by Country (2026-2031) & (K L)
 Table 43. Latin America Gadoterate Meglumine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gadoterate Meglumine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gadoterate Meglumine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gadoterate Meglumine Sales by Country (2020-2025) & (K L)
 Table 47. Middle East and Africa Gadoterate Meglumine Sales by Country (2026-2031) & (K L)
 Table 48. Middle East and Africa Gadoterate Meglumine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gadoterate Meglumine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gadoterate Meglumine Sales (K L) by Type (2020-2025)
 Table 51. Global Gadoterate Meglumine Sales (K L) by Type (2026-2031)
 Table 52. Global Gadoterate Meglumine Sales Market Share by Type (2020-2025)
 Table 53. Global Gadoterate Meglumine Sales Market Share by Type (2026-2031)
 Table 54. Global Gadoterate Meglumine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gadoterate Meglumine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gadoterate Meglumine Revenue Market Share by Type (2020-2025)
 Table 57. Global Gadoterate Meglumine Revenue Market Share by Type (2026-2031)
 Table 58. Global Gadoterate Meglumine Price (US$/L) by Type (2020-2025)
 Table 59. Global Gadoterate Meglumine Price (US$/L) by Type (2026-2031)
 Table 60. Global Gadoterate Meglumine Sales (K L) by Application (2020-2025)
 Table 61. Global Gadoterate Meglumine Sales (K L) by Application (2026-2031)
 Table 62. Global Gadoterate Meglumine Sales Market Share by Application (2020-2025)
 Table 63. Global Gadoterate Meglumine Sales Market Share by Application (2026-2031)
 Table 64. Global Gadoterate Meglumine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gadoterate Meglumine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gadoterate Meglumine Revenue Market Share by Application (2020-2025)
 Table 67. Global Gadoterate Meglumine Revenue Market Share by Application (2026-2031)
 Table 68. Global Gadoterate Meglumine Price (US$/L) by Application (2020-2025)
 Table 69. Global Gadoterate Meglumine Price (US$/L) by Application (2026-2031)
 Table 70. Guerbet Group Company Information
 Table 71. Guerbet Group Description and Business Overview
 Table 72. Guerbet Group Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. Guerbet Group Gadoterate Meglumine Product
 Table 74. Guerbet Group Recent Developments/Updates
 Table 75. Hengrui Medicine Company Information
 Table 76. Hengrui Medicine Description and Business Overview
 Table 77. Hengrui Medicine Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. Hengrui Medicine Gadoterate Meglumine Product
 Table 79. Hengrui Medicine Recent Developments/Updates
 Table 80. GE Healthcare Company Information
 Table 81. GE Healthcare Description and Business Overview
 Table 82. GE Healthcare Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 83. GE Healthcare Gadoterate Meglumine Product
 Table 84. GE Healthcare Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Gadoterate Meglumine Distributors List
 Table 88. Gadoterate Meglumine Customers List
 Table 89. Gadoterate Meglumine Market Trends
 Table 90. Gadoterate Meglumine Market Drivers
 Table 91. Gadoterate Meglumine Market Challenges
 Table 92. Gadoterate Meglumine Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gadoterate Meglumine
 Figure 2. Global Gadoterate Meglumine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gadoterate Meglumine Market Share by Type: 2024 & 2031
 Figure 4. 1.8845Gm/5Ml Product Picture
 Figure 5. 3.769Gm/10Ml Product Picture
 Figure 6. 5.6535Gm/15Ml Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Gadoterate Meglumine Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Gadoterate Meglumine Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Global Gadoterate Meglumine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Gadoterate Meglumine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Gadoterate Meglumine Sales (2020-2031) & (K L)
 Figure 15. Global Gadoterate Meglumine Average Price (US$/L) & (2020-2031)
 Figure 16. Gadoterate Meglumine Report Years Considered
 Figure 17. Gadoterate Meglumine Sales Share by Manufacturers in 2024
 Figure 18. Global Gadoterate Meglumine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Gadoterate Meglumine Players: Market Share by Revenue in Gadoterate Meglumine in 2024
 Figure 20. Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Gadoterate Meglumine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Gadoterate Meglumine Sales Market Share by Country (2020-2031)
 Figure 23. North America Gadoterate Meglumine Revenue Market Share by Country (2020-2031)
 Figure 24. United States Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Gadoterate Meglumine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Gadoterate Meglumine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Gadoterate Meglumine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Gadoterate Meglumine Revenue Market Share by Region (2020-2031)
 Figure 35. China Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Gadoterate Meglumine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Gadoterate Meglumine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Gadoterate Meglumine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Gadoterate Meglumine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Gadoterate Meglumine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Gadoterate Meglumine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Gadoterate Meglumine by Type (2020-2031)
 Figure 56. Global Gadoterate Meglumine Price (US$/L) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Gadoterate Meglumine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Gadoterate Meglumine by Application (2020-2031)
 Figure 59. Global Gadoterate Meglumine Price (US$/L) by Application (2020-2031)
 Figure 60. Gadoterate Meglumine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Gadodiamide Market Research Report 2024
Global Gadopentetate Dimeglumine Market Research Report 2024
Global Gadopentetic Acid Dimeglumine Salt Injection Market Research Report 2024
Global Gadolinium Contrast Media Market Research Report 2024
Global Gadolinium Contrast Medium Market Research Report 2025
Global Contrast Agents for Magnetic Resonance Imaging MRI Market Research Report 2024
Global MRI Contrast Agents Market Research Report 2025
Magnetic Resonance Imaging MRI Contrast Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gadolinium based Contrast Media Market Research Report 2024
Global MRI Contrast Media Agents Market Research Report 2025
Global Gadopentetate Dimeglumine API Market Research Report 2024
Gadolinium Contrast Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gadoteric Acid Meglumine Salt Injection Market Research Report 2025
Global Gadolinium Acetate Market Research Report 2024
Global Meglumine Diatrizoate Injection Market Research Report 2024
Global Gadolinium Oxalate Market Research Report 2024
Gadolinium III Oxide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Contrast Agent Market Insights Forecast to 2030
Global Magnetic Resonance Imaging Contrast Media Market Research Report 2024
Global Contrast Medium Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions